PLx Pharma

$7.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.03 (-12.67%) As of 7:36 PM UTC today

Why Robinhood?

You can buy or sell PLx Pharma and other stocks, options, and ETFs commission-free!

About PLXP

PLx Pharma Inc. Common Stock, also called PLx Pharma, is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ. The listed name for PLXP is PLx Pharma Inc. Common Stock.

CEO
Natasha Giordano
Employees
12
Headquarters
Sparta, New Jersey
Founded
2002
Market Cap
82.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
780.80K
High Today
$8.10
Low Today
$6.83
Open Price
$8.10
Volume
404.24K
52 Week High
$10.20
52 Week Low
$1.80

PLXP News

BenzingaMar 1

PLx Pharma Shares Rally After FDA Approves Supplemental New Drug Application

PLx Pharma Inc (NASDAQ: PLXP) shares were trading higher Monday after the company announced that the U.S. Food and Drug Administration approved a supplemental n

PLXP Earnings

-$0.49
-$0.33
-$0.16
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 12, After Hours

You May Also Like

ATKR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure